Structure-activity relationship of a new class of anti-hepatitis B virus agents

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 4004-4008

  Mehta, Anand ^a   Conyers, Bertha ^a   Tyrrell, D L J ^b   Walters, Kathie Anne ^b   Tipples, Graham A ^c   Dwek, Raymond A ^d   Block, Timothy M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CARBOHYDRATE DERIVATIVE; LAMIVUDINE; N NONYLDEOXYGALACTONOJIRIMYCIN; UNCLASSIFIED DRUG; DRUG DERIVATIVE; GALACTOSE;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; HEPATITIS B VIRUS; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS GENE; VIRUS MUTANT; CHEMISTRY; DRUG EFFECT;

ANTIVIRAL AGENTS; GALACTOSE; HEPATITIS B VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036896629     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.4004-4008.2002     Document Type: Article

References (23)

1. Beasley, R. P., and L. Y. Hwang. 1991. Overview on the epidemiology of hepatocellular carcinoma, p. 532-535. In F. B. Hollinger, S. M. Lemon, and M. Margolis (ed.), Viral Hepatitis and Liver Disease. The Williams & Willkins Co., Baltimore, Md.
2. Block, T., F. Platt, L. Xuanyong, W. Gerlich, G. Foster, B. Blumberg, and R. Dwek. 1994. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc. Natl. Acad. Sci. USA 91:2235-2239.
3. Block, T. M., X. Lu, A. Mehta, B. Blumberg, B. Tennant, M. Ebling, B. Korba, D. M. Lansky, G. S. Jacob, and R. A. Dwek. 1998. Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nat. Med. 4:610-614.
4. Doong, S. L., C. H. Tsai, R. F. Schinazi, D. C. Liotta, and Y. C. Cheng. 1991. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc. Natl. Acad. Sci. USA 88:8495-8499.
5. Durantel, D., N. Branza-Nichita, S. Carrouée-Durantel, T. D. Butters, R. A. Dwek, and N. Zitzmann. 2001. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus. J. Virol. 75:8987-8998.
6. Ganem, D. 1991. Assembly of hepadnaviral virions and subviral particles. Curr. Top. Microbiol. Immunol. 168:61-83.
7. Heermann, K. H., and W. H. Gerlich. 1992. Surface proteins of hepatitis B virus, p. 104-144. In A. Maclachlan (ed.), Molecular Biology of HBV. CRC Press, Boca Raton Fla.
8. Hollinger, F. B. 1990. Hepatitis B virus, p. 2171-2236. In B. N. Fields, D. M. Knipe, et al. (ed.), Fields Virology, vol. 2. Raven Press, Ltd., New York, N.Y.
9. Hoofnagle, J. H., and A. M. Di Bisceglie. 1997. Drug therapy: The treatment of chronic viral hepatitis. N. Engl. J. Med. 336:347-356.
10. Liaw, Y. F. 2001. Impact of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B. Antivir. Chem. Chemother. 12:67-71.
11. Lu, X., A. Mehta, T. Butters, R. A. Dwek, and T. M. Block. 1995. Evidence that N-linked glycosylation is necessary, for hepatitis B virus secretion. Virology 213:660-665.
12. Lu, X., A. Mehta, M. Dadmarz, R. A. Dwek, B. S. Blumberg, and T. M. Block. 1997. Aberrant trafficking and behavior of hepatitis B virus glycoproteins in cells in which glycosylation processing is inhibited. Proc. Natl. Acad. Sci. USA 94:2380-2385.
13. Mehta, A., X. Lu, R. A. Dwek, B. Blumberg, and T. M. Block. 1997. HBV envelope glycoproteins vary drastically in their sensitivity to glycan processing - Evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proc. Natl. Acad. Sci. USA 94:1822-1827.
14. Mehta, A., S. Carrouee, B. Conyers, R. Jordan, T. Butters, R. A. Dwek, and T. M. Block. 2001. Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: Therapeutic implications. Hepatology 33:1488-1495.
15. Ou, W. J., P. H. Cameron, D. Y. Thomas, and J. M. Bergeron. 1993. Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 364:771-776.
16. Platt, F. M., and T. D. Butters. 2000. New therapeutic prospects for the glycosphingolipid lysosomal storage diseases. Biochem. Pharmacol. 56:421-430.
17. Robinson, W. S. 1990. Hepadnaviridae and their replication, p. 2137-2169. In B. N. Fields, D. M. Knipe, et al. (ed.), Fields Virology. Raven Press, Ltd., New York, N.Y.
18. Sells, M. A., M. L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84:1005-1009.
19. Tan, A., L. van den Broek, S. van Boeckel, H. Ploegh, and J. Bolscher. 1991. Chemical modification of the glucosidase inhibitor 1-deoxynojirimycin. Structure-activity relationships. J. Biol. Chem, 266:14504-14510.
20. Terrault, N., and M. Ma. 2001. Adding to the hepatitis B virus treatment arsenal: Alpha-glucosidase inhibitor derivatives. Hepatology 33:1544-1546.
21. Tipples, G. A., M. Ma, K. P. Fischer, V. G. Bain, N. M. Kneteman, and D. L. J. Tyrrell. 1996. Mutation in the HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24:714-717.
22. Wei, Y., J. E. Tavis, and D. Ganem. 1996. Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses. J. Virol. 70:6455-6458.
23. Zitzmann, N., A. S. Mehta, S. Carrouée, T. D. Butters, F. M. Platt, J. McCauley, B. S. Blumberg, R. A. Dwek, and T. M. Block. 1999. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis agents. Proc. Natl. Acad. Sci. USA 96:11878-11882.